PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer
Abstract Background Liver cancer is the second leading causes of cancer-related death globally. Pyrroline-5-carboxylate reductase 1 (PYCR1) plays a critical role in metabolic profiles of tumors. Therefore, it is necessary to explore the mechanisms of PYCR1 on cell growth and survival in hepatocellul...
Main Authors: | Juhua Zhuang, Yanan Song, Ying Ye, Saifei He, Xing Ma, Miao Zhang, Jing Ni, Jiening Wang, Wei Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-019-2091-0 |
Similar Items
-
PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification
by: Haoyu Wang, et al.
Published: (2024-10-01) -
ITPKA phosphorylates PYCR1 and promotes the progression of glioma
by: Xiangying Luo, et al.
Published: (2024-08-01) -
Survival and clinicopathological significance of PYCR1 expression in cancer: A meta-analysis
by: Yue Li, et al.
Published: (2022-09-01) -
PYCR1 is associated with papillary renal cell carcinoma progression
by: Wang Qiu-Li, et al.
Published: (2019-08-01) -
Zebrafish Carrying <i>pycr1</i> Gene Deficiency Display Aging and Multiple Behavioral Abnormalities
by: Sung-Tzu Liang, et al.
Published: (2019-05-01)